F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding F-star Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 41 | 37 | −4 |
| Shares | 10.9M | 9.82M | −1.09M (−10.0%) |
| Value | $93.5M | $71.9M | −$21.6M (−23.1%) |
New holders (4)
Institutions that held F-star Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 15,547 | $114.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 500 | $4.00K | 0.00% |
| Group One Trading, L.P. | 200 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 171 | $1.00K | 0.00% |
Sold out (8)
Institutions that held F-star Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Verition Fund Management LLC | 187,331 | $1.61M |
| Alyeska Investment Group, L.P. | 150,000 | $1.29M |
| Maven Securities LTD | 144,932 | $1.26M |
| EcoR1 Capital, LLC | 46,000 | $395.0K |
| Dimensional Fund Advisors LP | 39,184 | $337.0K |
| ExodusPoint Capital Management, LP | 19,954 | $171.0K |
| Tiedemann Advisors, LLC | 17,243 | $148.0K |
| Cubist Systematic Strategies, LLC | 1,169 | $10.0K |